Probiotic treatment of rat pups normalises corticosterone release and ameliorates colonic dysfunction induced by maternal separation.
BACKGROUND
We previously showed that neonatal maternal separation (MS) of rat pups causes immediate and long-term changes in intestinal physiology.


OBJECTIVE
To examine if administration of probiotics affects MS-induced gut dysfunction.


METHODS
MS pups were separated from the dam for 3 h/day from days 4 to 19; non-separated (NS) pups served as controls. Twice per day during the separation period, 10(8) probiotic organisms (two strains of Lactobacillus species) were administered to MS and NS pups; vehicle-treated pups received saline. Studies were conducted on day 20, when blood was collected for corticosterone measurement as an indication of hypothalamus-pituitary-adrenal (HPA) axis activity, and colonic function was studied in tissues mounted in Ussing chambers. Ion transport was indicated by baseline and stimulated short-circuit current (Isc); macromolecular permeability was measured by flux of horseradish peroxidase (HRP) across colonic tissues; and bacterial adherence/penetration into the mucosa was quantified by culturing tissues in selective media. Colonic function and host defence were also evaluated at day 60.


RESULTS
Isc and HRP flux were significantly higher in the colon of MS versus NS pups. There was increased adhesion/penetration of total bacteria in MS pups, but a significant reduction in Lactobacillus species. Probiotic administration ameliorated the MS-induced gut functional abnormalities and bacterial adhesion/penetration at both day 20 and 60, and reduced the elevated corticosterone levels at day 20.


CONCLUSIONS
The results indicate that altered enteric flora are responsible for colonic pathophysiology. Probiotics improve gut dysfunction induced by MS, at least in part by normalisation of HPA axis activity.
Gareau
Mélanie G
MG
Intestinal Disease Research Program, Department of Pathology and Molecular Medicine, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada. melanie.gareau@utoronto.ca
Jury
Jennifer
J
MacQueen
Glenda
G
Sherman
Philip M
PM
Perdue
Mary H
MH
D000818:Animals; D000831:Animals, Newborn; D003345:Corticosterone / Q000378:metabolism*; D005260:Female; D005767:Gastrointestinal Diseases / Q000517:prevention & control / Q000523:psychology*; D007778:Lactobacillus; D008426:Maternal Deprivation; D019936:Probiotics / Q000627:therapeutic use*; D011897:Random Allocation; D051381:Rats; D017207:Rats, Sprague-Dawley; D013315:Stress, Psychological / Q000150:complications* / Q000378:metabolism; D016896:Treatment Outcome
D003345:Corticosterone